431 related articles for article (PubMed ID: 22607851)
1. Rationale and design of the PRAETORIAN trial: a Prospective, RAndomizEd comparison of subcuTaneOus and tRansvenous ImplANtable cardioverter-defibrillator therapy.
Olde Nordkamp LR; Knops RE; Bardy GH; Blaauw Y; Boersma LV; Bos JS; Delnoy PP; van Dessel PF; Driessen AH; de Groot JR; Herrman JP; Jordaens LJ; Kooiman KM; Maass AH; Meine M; Mizusawa Y; Molhoek SG; van Opstal J; Tijssen JG; Wilde AA
Am Heart J; 2012 May; 163(5):753-760.e2. PubMed ID: 22607851
[TBL] [Abstract][Full Text] [Related]
2. [Transvenous subcutaneous implantation technique of the cardioverter/defibrillator].
Block M; Hammel D; Borggrefe M; Scheld HH; Breithardt G
Herz; 1994 Oct; 19(5):259-77. PubMed ID: 8001899
[TBL] [Abstract][Full Text] [Related]
3. Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy?
Ellenbogen KA; Levine JH; Berger RD; Daubert JP; Winters SL; Greenstein E; Shalaby A; Schaechter A; Subacius H; Kadish A;
Circulation; 2006 Feb; 113(6):776-82. PubMed ID: 16461817
[TBL] [Abstract][Full Text] [Related]
4. Rationale and design of the PRAETORIAN-DFT trial: A prospective randomized CompArative trial of SubcutanEous ImplanTable CardiOverter-DefibrillatoR ImplANtation with and without DeFibrillation testing.
Quast ABE; Baalman SWE; Betts TR; Boersma LVA; Bonnemeier H; Boveda S; Brouwer TF; Burke MC; Delnoy PPHM; El-Chami M; Kuschyk J; Lambiase P; Marquie C; Miller MA; Smeding L; Wilde AAM; Knops RE
Am Heart J; 2019 Aug; 214():167-174. PubMed ID: 31220775
[TBL] [Abstract][Full Text] [Related]
5. Development of the subcutaneous implantable cardioverter-defibrillator for reducing sudden cardiac death.
Sanghera R; Sanders R; Husby M; Bentsen JG
Ann N Y Acad Sci; 2014 Nov; 1329():1-17. PubMed ID: 25308791
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of a totally subcutaneous implantable-cardioverter defibrillator.
Weiss R; Knight BP; Gold MR; Leon AR; Herre JM; Hood M; Rashtian M; Kremers M; Crozier I; Lee KL; Smith W; Burke MC
Circulation; 2013 Aug; 128(9):944-53. PubMed ID: 23979626
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and Safety of Appropriate Shocks and Antitachycardia Pacing in Transvenous and Subcutaneous Implantable Defibrillators: Analysis of All Appropriate Therapy in the PRAETORIAN Trial.
Knops RE; van der Stuijt W; Delnoy PPHM; Boersma LVA; Kuschyk J; El-Chami MF; Bonnemeier H; Behr ER; Brouwer TF; Kääb S; Mittal S; Quast ABE; Smeding L; Tijssen JGP; Bijsterveld NR; Richter S; Brouwer MA; de Groot JR; Kooiman KM; Lambiase PD; Neuzil P; Vernooy K; Alings M; Betts TR; Bracke FALE; Burke MC; de Jong JSSG; Wright DJ; Jansen WPJ; Whinnet ZI; Nordbeck P; Knaut M; Philbert BT; van Opstal JM; Chicos AB; Allaart CP; Borger van der Burg AE; Clancy JF; Dizon JM; Miller MA; Nemirovsky D; Surber R; Upadhyay GA; Weiss R; de Weger A; Wilde AAM; Olde Nordkamp LRA;
Circulation; 2022 Feb; 145(5):321-329. PubMed ID: 34779221
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of celivarone, with amiodarone as calibrator, in patients with an implantable cardioverter-defibrillator for prevention of implantable cardioverter-defibrillator interventions or death: the ALPHEE study.
Kowey PR; Crijns HJ; Aliot EM; Capucci A; Kulakowski P; Radzik D; Roy D; Connolly SJ; Hohnloser SH;
Circulation; 2011 Dec; 124(24):2649-60. PubMed ID: 22082672
[TBL] [Abstract][Full Text] [Related]
9. An entirely subcutaneous implantable cardioverter-defibrillator.
Bardy GH; Smith WM; Hood MA; Crozier IG; Melton IC; Jordaens L; Theuns D; Park RE; Wright DJ; Connelly DT; Fynn SP; Murgatroyd FD; Sperzel J; Neuzner J; Spitzer SG; Ardashev AV; Oduro A; Boersma L; Maass AH; Van Gelder IC; Wilde AA; van Dessel PF; Knops RE; Barr CS; Lupo P; Cappato R; Grace AA
N Engl J Med; 2010 Jul; 363(1):36-44. PubMed ID: 20463331
[TBL] [Abstract][Full Text] [Related]
10. Subcutaneous or Transvenous Defibrillator Therapy.
Knops RE; Olde Nordkamp LRA; Delnoy PHM; Boersma LVA; Kuschyk J; El-Chami MF; Bonnemeier H; Behr ER; Brouwer TF; Kääb S; Mittal S; Quast ABE; Smeding L; van der Stuijt W; de Weger A; de Wilde KC; Bijsterveld NR; Richter S; Brouwer MA; de Groot JR; Kooiman KM; Lambiase PD; Neuzil P; Vernooy K; Alings M; Betts TR; Bracke FALE; Burke MC; de Jong JSSG; Wright DJ; Tijssen JGP; Wilde AAM;
N Engl J Med; 2020 Aug; 383(6):526-536. PubMed ID: 32757521
[TBL] [Abstract][Full Text] [Related]
11. Preventive effectiveness of implantable cardioverter defibrillator in reducing sudden cardiac death in the Chinese population: a multicenter trial of ICD therapy versus non-ICD therapy.
Hua W; Niu H; Fan X; Ding L; Xu YZ; Wang J; Chen K; Wang F; Zhang S;
J Cardiovasc Electrophysiol; 2012 Nov; 23 Suppl 1():S5-9. PubMed ID: 23140347
[TBL] [Abstract][Full Text] [Related]
12. [The implantable cardioverter/defibrillator (ICD). Developments up to the present time and future perspectives].
Brachmann J; Hilbel T; Schöls W; Beyer T; Schweizer M; Sterns L; Karolyi L; Melichercik J; Freigang KD; Kübler W
Herz; 1994 Oct; 19(5):246-50. PubMed ID: 8001897
[TBL] [Abstract][Full Text] [Related]
13. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
[TBL] [Abstract][Full Text] [Related]
14. [Complications in transvenous and transvenous-subcutaneous implantable defibrillator systems].
Podczeck A; Hief C; Veit F; Jakl G; Kaltenbrunner W; Nürnberg M; Frohner K; Steinbach K
Z Kardiol; 1994 May; 83(5):366-72. PubMed ID: 8053246
[TBL] [Abstract][Full Text] [Related]
15. The Midlands Trial of Empirical Amiodarone versus Electrophysiology-guided Interventions and Implantable Cardioverter-defibrillators (MAVERIC): a multi-centre prospective randomised clinical trial on the secondary prevention of sudden cardiac death.
Lau EW; Griffith MJ; Pathmanathan RK; Ng GA; Clune MM; Cooper J; Marshall HJ; Forsey PR; Stafford PJ; Gray RG; Skehan JD; Garratt CJ
Europace; 2004 Jul; 6(4):257-66. PubMed ID: 15172648
[TBL] [Abstract][Full Text] [Related]
16. Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) trial results.
Wathen MS; DeGroot PJ; Sweeney MO; Stark AJ; Otterness MF; Adkisson WO; Canby RC; Khalighi K; Machado C; Rubenstein DS; Volosin KJ;
Circulation; 2004 Oct; 110(17):2591-6. PubMed ID: 15492306
[TBL] [Abstract][Full Text] [Related]
17. Prevention of sudden cardiac death: the role of the implantable cardioverter-defibrillator.
Sinha SK; Mehta D; Gomes JA
Mt Sinai J Med; 2005 Jan; 72(1):1-9. PubMed ID: 15682255
[TBL] [Abstract][Full Text] [Related]
18. Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator. Active Can Investigators.
Bardy GH; Yee R; Jung W
J Am Coll Cardiol; 1996 Aug; 28(2):400-10. PubMed ID: 8800117
[TBL] [Abstract][Full Text] [Related]
19. Shock Without Wires: A Look at Subcutaneous Implantable Cardioverter-Defibrillator Compared to Transvenous Implantable Cardioverter-Defibrillator for Ventricular Arrhythmias.
Raja J; Guice K; Oberoi M; Whitwell S; Asbeutah AA; Russell A; Khouzam RN
Curr Probl Cardiol; 2022 Sep; 47(9):100927. PubMed ID: 34311985
[TBL] [Abstract][Full Text] [Related]
20. Subcutaneous implantable cardioverter-defibrillator (S-ICD).
Lobodzinski SS
Cardiol J; 2011; 18(3):326-31. PubMed ID: 21660928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
